Details for Patent: 6,235,756
✉ Email this page to a colleague
Summary for Patent: 6,235,756
Title: | Methods and compositions for inhibition of angiogenesis by thalidomide |
Abstract: | The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally. |
Inventor(s): | D'Amato; Robert (Lancaster, PA) |
Assignee: | The Children's Medical Center Corporation (Boston, MA) |
Application Number: | 08/918,610 |
Patent Claim Types: see list of patent claims | Use; Dosage form; Formulation; |
Drugs Protected by US Patent 6,235,756
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,235,756
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 218865 | ⤷ Try a Trial | |||
Austria | 304356 | ⤷ Try a Trial | |||
Australia | 6248694 | ⤷ Try a Trial | |||
Australia | 676722 | ⤷ Try a Trial | |||
Brazil | 9400764 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |